As ACSL4 is an essential enzyme that incorporates PUFAs, such as AA, into phospholipids, a critical step to ferroptosis, the authors showed that RB loss increased lipid peroxidation and ferroptotic potential of cancer cells, which was abolished upon concurrent ACSL4 inhibition. This evidence concerns the gene ACSL4 and cancer.